Skip to main content
Home / Current Medicinal Chemistry, Volume 21, Number 35
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 21, Number 35, 2014

Articles

System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
pp. 3985-3998(14)
Author: Sebastian Yakisich, Juan

Favourites:
ADD

Association Between Polycystic Ovary Syndrome and Metabolic Syndrome
pp. 3999-4012(14)
Authors: Martin Velez, Leandro; Beatriz Motta, Alicia

Favourites:
ADD

Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective
pp. 4013-4045(33)
Authors: Kushwaha, R.N.; Haq, W.; Katti, S.B.

Favourites:
ADD

Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases
pp. 4046-4058(13)
Authors: Carbone, Federico; Mach, Francois; Vuilleumier, Nicolas; Montecucco, Fabrizio

Favourites:
ADD

Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment
pp. 4059-4073(15)
Authors: Skupin-Mrugalska, P.; Sobotta, L.; Kucinska, M.; Murias, M.; Mielcarek, J.; Duzgunes, N.

Favourites:
ADD

α-Glucan Pathway as a Novel Mtb Drug Target: Structural Insights and Cues for Polypharmcological Targeting of GlgB and GlgE
pp. 4074-4084(11)
Authors: Agrawal, Pushpa; Gupta, Pawan; Swaminathan, Kunchithapadam; Parkesh, Raman

Favourites:
ADD

Clearance of Beta-Amyloid in the Brain
pp. 4085-4090(6)
Authors: Ueno, Masaki; Chiba, Yoichi; Matsumoto, Koichi; Nakagawa, Toshitaka; Miyanaka, Hiroshi

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content